Advertisement

Topics

Cardium Therapeutics Company Profile

23:58 EDT 25th September 2017 | BioPortfolio

Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications, which are leading healthcare priorities in the U.S. and the world. We are in the process of building a business that balances products for “today” that are either currently marketed or have advanced to near-term sales or partnering opportunities, as well as breakthrough products for “tomorrow”. We are leading a revolution into the new frontiers of cardiovascular and regenerative medicine and are assembling a portfolio of forward-focused therapeutic biologics and medical devices designed to transform the practice of medicine. They each have well-defined commercial pathways and represent substantial economic opportunities. While varied in approach, our portfolio is uniformly directed to the prevention and treatment of ischemic injuries. Our biologics and medical devices are designed to leverage the human body’s natural capacity to heal, protect and repair. Unlike small molecule, chronic-use drugs that typically provide only symptomatic relief, the planned products in our portfolio are being designed for one-time application to heal and repair the underlying medical condition or to prevent further injury in acute or surgical settings.

Location

3611 Valley Centre, Suite 525
San Diego
CA
92130
United States of America

Contact

Phone: (858) 436-1000
Fax: (858) 436-1001
Email: investorrelations@cardiumthx.com


News Articles [1533 Associated News Articles listed on BioPortfolio]

Cardium Announces $5.0 Million Financing With Institutional Investors

  SAN DIEGO, Feb. 13, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today announced that it has entered into definitive agreements with three institutional and accredited inv...

Cardium Regains Listing Compliance With NYSE Amex

SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that it had received notice from NYSE Regulation that the Company is now considered to have regained c...

Cardium To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives

SAN DIEGO, Jan. 4, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, the Company's Chairman & CEO, will present at the Biotech Showcase 2...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Taxus Cardium Release: Excellagen Receives Notice Of Allowance For A New Patent Application Covering Blood Platelet Activation & Endogeneous Growth Factor Release For Wound Repair And Tissue Regeneration

  Life Sciences Jobs   ...

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Summit Therapeutics PLC (SMMT) and Orexigen Therapeutics (OREX) Head to Head Review

Summit Therapeutics PLC and Orexigen Therapeutics are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, in...

Clinical Trials [117 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1148 Associated Companies listed on BioPortfolio]

Cardium Therapeutics, Inc.

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sal...

Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. is a holding company that operates Cardium Therapeutics, a development stage advanced regenerative therapeutics company focused on the lat...

Cardium Therapeutics

Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications, which are leadi...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Cardium Therapeutics" on BioPortfolio

We have published hundreds of Cardium Therapeutics news stories on BioPortfolio along with dozens of Cardium Therapeutics Clinical Trials and PubMed Articles about Cardium Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardium Therapeutics Companies in our database. You can also find out about relevant Cardium Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record